Atlas Trials

Observational Study of the Combination of Post-transplant High Dose Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-versus-Host Disease in Patients Eligible to Allogeneic Hematopoietic Stem Cell Transplant

Clinical trial NCT02300571 · UNKNOWN

Trial details

NCT number
NCT02300571
Sponsor
Fondazione del Piemonte per l'Oncologia
Status
UNKNOWN
Study type
OBSERVATIONAL
Hematological Malignancies
Start date
2013-09-01
Primary completion
2017-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.